The recent announcement by the Clinical Ophthalmology Research Group at the University of Oxford that two patients were able to achieve some restoration of vision following implantation of the Alpha IMS device puts maker Retina Implant AG ahead of the pack in the bionic eye space, according to an analyst with research and consulting firm GlobalData.
Shashank Settipalli, GlobalData’s Analyst covering Medical Devices, says: “These promising results, in conjunction with a string of positive
Read More
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Footer
